G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $121,943,000 | -6.4% | 9,087 | +34.8% | 0.03% | -3.3% |
| Q2 2021 | $130,301,000 | -11.4% | 6,741 | +10.3% | 0.03% | -28.6% |
| Q1 2021 | $147,000,000 | +32.9% | 6,110 | -0.7% | 0.04% | +27.3% |
| Q4 2020 | $110,633,000 | +64.3% | 6,150 | +5.5% | 0.03% | +65.0% |
| Q3 2020 | $67,333,000 | -51.9% | 5,830 | +1.1% | 0.02% | -45.9% |
| Q2 2020 | $139,898,000 | +121.3% | 5,767 | +0.5% | 0.04% | +105.6% |
| Q1 2020 | $63,230,000 | – | 5,738 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |